An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03532542 |
|
Recruitment Status :
Enrolling by invitation
First Posted : May 22, 2018
Last Update Posted : August 5, 2022
|
Sponsor:
Sarepta Therapeutics, Inc.
Information provided by (Responsible Party):
Sarepta Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Enrolling by invitation |
|---|---|
| Estimated Primary Completion Date : | August 10, 2026 |
| Estimated Study Completion Date : | August 10, 2026 |